Product Information
VERAPAMIL SR 240 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.1423 per EA under NDC 00591288401. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
240 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00591288401
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019614On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 240 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 67.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1423 per EA |
|---|---|
| All-time high | $2.7190 (Apr 15, 2026) |
| All-time low | $0.6094 (Feb 18, 2015) |
| 52-week high | $2.7190 |
| 52-week low | $1.0442 |
| Median price | $1.3665 |
| Average price | $1.3052 |
| Largest weekly change | +72.9% (May 20, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 240 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 240 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.1423 per EA (NDC 00591288401), effective Jun 24, 2026.
How has the price of VERAPAMIL SR 240 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 240 MG CAPSULE has risen 67.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 240 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VERAPAMIL SR 240 MG CAPSULE has ranged from a low of $0.6094 (Feb 18, 2015) to a high of $2.7190 (Apr 15, 2026), with a median of $1.3665 per EA.
Are there cheaper alternatives to VERAPAMIL SR 240 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VERAPAMIL ER 240 MG TABLET, is $0.1663 per EA — about 85% below VERAPAMIL SR 240 MG CAPSULE.
Who manufactures VERAPAMIL SR 240 MG CAPSULE?
VERAPAMIL SR 240 MG CAPSULE (NDC 00591288401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification